Related Experiment Video
Updated: May 15, 2026

11:14
Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
Published on: November 7, 2018
18.4K
Advances in isothermal nucleic acid amplification methods for hepatitis B virus detection
Huilin Li1, Wenjun Song1, Hongying Li1
1State Key Laboratory of Southwestern Chinese Medicine Resources, Chengdu University of Traditional Chinese Medicine, Chengdu, China. chenrong@cdutcm.edu.cn.
The Analyst
|July 25, 2023
Summary
Hepatitis B virus (HBV) diagnosis is advancing beyond serological assays. Molecular assays, particularly isothermal nucleic acid amplification methods, offer more accurate detection for HBV DNA positive, HBsAg negative cases.
Area of Science:
- Virology
- Molecular Biology
- Diagnostics
Background:
- Hepatitis B virus (HBV) infection remains a significant global health concern.
- Serological assays detecting HBsAg are standard for HBV diagnosis but miss some cases.
- Increasing identification of HBV DNA positive, HBsAg negative individuals necessitates advanced diagnostic approaches.
Purpose of the Study:
- To provide a comprehensive review of nucleic acid isothermal amplification technologies for HBV detection.
- To compare the analytical performance of various isothermal amplification methods.
- To discuss the integration of these technologies with microfluidics, lateral flow assays, and CRISPR/Cas systems.
Main Methods:
- Review of current literature on nucleic acid amplification testing (NAT) for HBV.
- Focus on non-PCR-based isothermal amplification techniques (NASBA, RCA, LAMP, HDA, RPA).
- Analysis of method integration with advanced platforms for point-of-care testing (POCT).
Main Results:
- Isothermal amplification methods offer sensitive and rapid HBV detection, suitable for POCT.
- Non-PCR based methods are gaining prominence for next-generation NAT due to their isothermal nature.
- Integration with microfluidics, lateral flow, and CRISPR/Cas enhances diagnostic capabilities.
Conclusions:
- Nucleic acid isothermal amplification technologies are crucial for accurate and accessible HBV diagnosis.
- These methods represent a significant advancement over traditional serological assays.
- Future directions include further optimization and integration for widespread clinical application.

